Our Team
Rachel Sabol, MD, PhD
 |
Education |
- Radiation Oncology Residency, University of California, San Francisco (2022-2026)
- Preliminary Medicine Internship, California Pacific Medical Center (2021-2022)
- MD/PhD, Physician Scientist Program, Tulane University School of Medicine (2014-2021)
- MS, Neuroscience, Tulane University (2013-2014)
- BS, Cell and Molecular Biology, Tulane University (2010-2013)
 |
Awards & Honors |
- Best Resident Research, California Pacific Medical Center, 2022
- Recognition of Meritorious Research in the Field of Medicine, Jacob Ambros Storck Prize, Tulane University, 2021
- Center for Clinical and Translation Research TL1 Training Grant, 2017-2018
- Student Research Award, Southern Society for Clinical Investigators, 2018
- Liz Early Prize for Outstanding Undergraduate Research, Tulane University, 2013
 |
Selected Publications and Abstracts |
- Sabol RA, Roach M. Editorial Comment. J Urol. 2022 Dec; 208(6):1238-1239. PMID 36349917
- Matossian MD, Chang T, Wright MK, Burks HE, Elliott S, Sabol RA, Wathieu H, Windsor G, Alzoubi M, King CT, Bursavich JB, Ham AM, Savoie JJ, Ngyuen K, Baddoo M, Flemington E, Sirenko O, Cromwell EF, Hebert KL, Lau F, Izadpanah R, Brown H, Sinha S, Zabaleta J, Riker AI, Moroz K, Miele L, Zea A, Ochoa A, Bunnell BA, Collins-Burow BM, Martin EC, Burow ME. In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types. Clin Transl Oncol. 2022 Jan;24(1):127-144. PMID: 34370182
- Sabol RA, Ledet EM, Jaeger E, Hatton W, Moses M, Lankford A, Zaheria A, Barata P, Layton JL, Lewis BE, Sartor O. Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients. Prostate. 2021 May;81(7):427-432. PMID: 33760238
- Chang TC*, Matossian MD*, Elliott S, Burks HE, Sabol RA, Ucar DA, Wathieu H, Zableta J, DeValle L, Gill S, Martin E, Riker AI, Miele L, Bunnell BA, Burow ME, Collins-Burow BM. Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor. PLoS ONE. 2020 Oct 9;15(10). PMID: 33035223
- Sabol RA, Bubenzer V, Moroz K, Halat S, Dang A, Ferdinand K, Traylor A, Boyd C, Harris K. Image-guided intensity-modulated radiation therapy for IgG4-related ophthalmic disease. Case Rep in Ophthalmol Med. 2020 Sep 5. PMID: 32963860
- Matossian MD, Burks HE, Elliott S, Hoang VT, Zuercher WJ, Wells C, Drery HD, Kapadia N, Chang T, Yan T, Windsor GO, Nguyen K, Fang G, Nephew KP, Buechlein A, Rusch DB, Sabol RA, Ucar DA, Zabaleta J, Miele L, Bunnell BA, Collins-Burow BM, Burow ME. A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple negative breast cancer to identify targetable signaling pathways. Anticancer Drugs. 2020 Sept;31(8):758-775. PMID: 32796402
- Sabol RA, Villela VA, Denys A, Freeman BT, Hartono AB, Wise RM, Harrison MAA, Sandler MB, Hossain F, Miele L, Bunnell BA. Obesity-altered adipose stem cells promote radiation resistance of estrogen receptor positive breast cancer through paracrine signaling. Int J Mol Sci. 2020 Apr 15;21(8):1-15. PMID: 32326381
- Pashos NC, Graham DM, Burkett BJ, O’Donnell B, Sabol RA, Helm J, Martin EC, Bowles AC, Heim WM, Caronna V, Miller KS, Grasperge BF, Sullivan S, Chaffin AE, Bunnell BA. Acellular Nipple-Areolar Complex Graft: In Vivo Murine & Non-Human Primate Host Response Evaluation. Tissue Eng Part A. 2020 Jan 17;26(15-16):872-885. PMID: 31950890
- Sabol RA, Giacomelli P, Beighley A, Bunnell BA. Adipose Stem Cells and Cancer: Concise Review. Stem Cells. 2019 Oct;37(10):1261-1266. PMID: 31271683
- McLoughlin MR, Orlicky DJ, Prigge JR, Krishna P, Talago EA, Cavigli IR, Eriksson S, Miller CG, Kundert JA, Sayin VI, Sabol RA, Heinemann J, Brandenberger LO, Iverson SV, Bothner B, Papagiannakopoulos T, Shearn CT, Arnér ESJ, Schmidt EE. TrxR1, Gsr, and oxidative stress determine hepatocellular carcinoma malignancy. Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11408-11417. PMID: 31097586.
- Sabol RA, Bowles AC, Côté A, Wise R, O’Donnell B, Matossian MD, Hossain FM, Burks HE, Miele L, Collins-Burow BM, Burow ME, Bunnell BA. Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumor growth of triple negative breast cancer in orthotopic xenograft and patient-derived xenograft models. Breast Cancer Research. 2019 May 22;21(1):67. PMID: 31118047.
- Sabol RA, Beighley A, Giacomelli P, Wise RM, Harrison MAA, O’Donnell B, Sullivan BN, Lampenfeld J, Matossian MD, Bratton MR, Wang G, Collins-Burow BM, Burow ME, Bunnell BA. Obesity-altered adipose stem cells promote ER+ breast cancer metastasis through estrogen independent pathways. Int. J Mol Sci. 2019 Mar 20;20(6). PMID: 30897853.
- Matossian MD, Burks HE, Elliott S, Hoang VT, Bowles AC, Sabol RA, Wahba B, Anbalagan M, Rowan B, Abazeed ME, Bunnell BA, Moroz K, Miele L, Rhodes LV, Jones SD, Martin EC, Collins-Burow BM, Burow ME. Drug resistance profiling of a triple negative breast cancer patient-derived xenograft model. BMC Cancer. 2019 Mar 7;19(1):205. PMID: 30845999.
- Sabol RA, Bunnell BA. Discussion: CRISPER/Cas9-mediated BRCA knockdown Adipose Stem Cells Promote Breast Cancer Progression. Plastic and Reconstructive Surgery. 2019 Mar;143(3):757-758. PMID: 30817647.
- Sabol RA, Bowles AC, Côté A, Wise R, Pashos N, Bunnell BA. (2018) Therapeutic Potential of Adipose Stem Cells. Advances in Experimental Medicine and Biology. Springer, New York, NY. 2018 Jul 27. PMID: 30051318.
- Matossian MD, Burks HE, Bowles AC, Elliott S, Barnes VT, Sabol RA, Pashos N, O’Donnell B, Miller K, Wahba B, Bunnell BA, Moroz K, Zea AH, Jones SD, Riker AI, Rhodes LV, Martin E, Miele L, Burow ME, Collins-Burow BM. A novel patient-derived xenograft model for claudin-low triple-negative breast cancer. Breast Cancer Res and Treat. 2018 Jun;169(2):381-390. PMID: 29392581.
- Matossian MD, Burks HE, Elliott S, Hoang VT, Bowles AC, Sabol RA, Bunnell BA, Martin EC, Burow ME, Collins-Burow BM. Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model. Oncoscience. 2018 Apr 29;5(3-4):99-108. PMID: 29854878.
- Sabol RA*, Noxon V*, Sartor, O, Berger JR, Quereshi Z, Raisch DW, Norris LB, Yarnold PR, Georgantopoulos P, Hrushesky WJ, Bobolts L, Ray P, Lebby A, Krane RC, Bennett CL. Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR). Cancer Med. 2017 Jul;6(7):1541-1551. PMID: 28635055. *co-first authors